NYSE:NVRO - Nevro Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$59.43 +0.53 (+0.90 %)
(As of 07/22/2018 04:00 PM ET)
Previous Close$59.43
Today's Range$59.00 - $60.2782
52-Week Range$54.87 - $94.34
Volume438,274 shs
Average Volume1.20 million shs
Market Capitalization$1.78 billion
P/E RatioN/A
Dividend YieldN/A
Beta-0.59
Nevro logoNevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.

Receive NVRO News and Ratings via Email

Sign-up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNYSE:NVRO
CUSIPN/A
Phone650-251-0005

Debt

Debt-to-Equity Ratio0.61
Current Ratio7.99
Quick Ratio6.17

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$326.67 million
Price / Sales5.45
Cash FlowN/A
Price / CashN/A
Book Value$8.41 per share
Price / Book7.07

Profitability

EPS (Most Recent Fiscal Year)($1.25)
Net Income$-36,650,000.00
Net Margins-11.53%
Return on Equity-16.32%
Return on Assets-9.07%

Miscellaneous

Employees676
Outstanding Shares29,980,000
Market Cap$1,781.65

Nevro (NYSE:NVRO) Frequently Asked Questions

What is Nevro's stock symbol?

Nevro trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVRO."

How were Nevro's earnings last quarter?

Nevro Corp (NYSE:NVRO) issued its earnings results on Thursday, February, 22nd. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.01. The medical equipment provider earned $97.96 million during the quarter, compared to analyst estimates of $96.87 million. Nevro had a negative net margin of 11.53% and a negative return on equity of 16.32%. The firm's revenue was up 38.9% compared to the same quarter last year. During the same period last year, the business earned ($0.34) EPS. View Nevro's Earnings History.

When is Nevro's next earnings date?

Nevro is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Nevro.

What price target have analysts set for NVRO?

10 equities research analysts have issued 12-month price targets for Nevro's shares. Their predictions range from $62.00 to $105.00. On average, they anticipate Nevro's stock price to reach $84.5556 in the next year. This suggests a possible upside of 42.3% from the stock's current price. View Analyst Ratings for Nevro.

What is the consensus analysts' recommendation for Nevro?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nevro in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Nevro's key competitors?

Who are Nevro's key executives?

Nevro's management team includes the folowing people:
  • Mr. Rami Elghandour, Pres, CEO & Director (Age 39)
  • Mr. Andrew H. Galligan, Chief Financial Officer (Age 62)
  • Mr. Patrick Schmitz, VP of Operations (Age 58)
  • Mr. James Alecxih, VP of Worldwide Sales (Age 53)
  • Mr. Doug Alleavitch, VP of Quality (Age 57)

Has Nevro been receiving favorable news coverage?

News stories about NVRO stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Nevro earned a daily sentiment score of 0.24 on Accern's scale. They also assigned media stories about the medical equipment provider an impact score of 44.90 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Nevro's major shareholders?

Nevro's stock is owned by many different of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (1.24%), Hardman Johnston Global Advisors LLC (0.32%), ZWJ Investment Counsel Inc. (0.16%), Bank of Montreal Can (0.10%), Essex Investment Management Co. LLC (0.03%) and Xact Kapitalforvaltning AB (0.01%). Company insiders that own Nevro stock include Andrew H Galligan, Doug Alleavitch, Michael Enxing, Michael F Demane, Rami Elghandour and Wilfred E Jaeger. View Institutional Ownership Trends for Nevro.

Which institutional investors are selling Nevro stock?

NVRO stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can and Hardman Johnston Global Advisors LLC. Company insiders that have sold Nevro company stock in the last year include Andrew H Galligan, Michael F Demane and Wilfred E Jaeger. View Insider Buying and Selling for Nevro.

Which institutional investors are buying Nevro stock?

NVRO stock was acquired by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Essex Investment Management Co. LLC, ZWJ Investment Counsel Inc. and Xact Kapitalforvaltning AB. View Insider Buying and Selling for Nevro.

How do I buy shares of Nevro?

Shares of NVRO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nevro's stock price today?

One share of NVRO stock can currently be purchased for approximately $59.43.

How big of a company is Nevro?

Nevro has a market capitalization of $1.78 billion and generates $326.67 million in revenue each year. The medical equipment provider earns $-36,650,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis. Nevro employs 676 workers across the globe.

How can I contact Nevro?

Nevro's mailing address is 1800 BRIDGE PARKWAY, REDWOOD CITY CA, 94065. The medical equipment provider can be reached via phone at 650-251-0005 or via email at [email protected]


MarketBeat Community Rating for Nevro (NYSE NVRO)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  314 (Vote Outperform)
Underperform Votes:  181 (Vote Underperform)
Total Votes:  495
MarketBeat's community ratings are surveys of what our community members think about Nevro and other stocks. Vote "Outperform" if you believe NVRO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVRO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.